five

Available IPD datapackage for study 'Multicenter, Randomised, Double-blind Phase III Trial to Investigate the Efficacy and Safety of BIBF 1120 in Combination With Carboplatin and Paclitaxel Compared to Placebo Plus Carboplatin and Paclitaxel in Patients With Advanced Ovarian Cancer'

收藏
DataCite Commons2025-08-06 更新2026-05-07 收录
下载链接:
https://search.vivli.org/doiLanding/dataPackages/PR00005243.0
下载链接
链接失效反馈
官方服务:
资源简介:
The trial will be performed to evaluate if BIBF 1120 in combination with paclitaxel and carboplatin is more effective than placebo in combination with paclitaxel and carboplatin in first-line treatment of patients with advanced ovarian cancer. Safety information about BIBF1120/paclitaxel/carboplatin will be obtained.
提供机构:
Vivli
创建时间:
2025-08-06
二维码
社区交流群
二维码
科研交流群
商业服务